Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on S adenosylmethionine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111235084A reveals a cost-effective enzymatic route for S-adenosylmethionine using recombinant E. coli, offering significant supply chain advantages.
Patent CN109136311B reveals cost-effective SAM production. Adenosine substrate replaces ATP. Reliable supplier for pharma intermediates.
Patent CN114277073A reveals gene-knockout method for high-purity SAM. Reduces purification costs and ensures supply chain stability for pharmaceutical intermediates.